デフォルト表紙
市場調査レポート
商品コード
1091251

世界のDPTワクチン接種市場:考察と予測 (2028年まで)

Global DPT Vaccination Market Insights, Forecast to 2028

出版日: | 発行: QYResearch | ページ情報: 英文 93 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円
世界のDPTワクチン接種市場:考察と予測 (2028年まで)
出版日: 2022年06月20日
発行: QYResearch
ページ情報: 英文 93 Pages
納期: 2~3営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、DPTワクチン接種 (DPT Vaccination) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • DPTワクチン接種の製品概要
  • 市場:タイプ別
    • 世界のDPTワクチン接種の市場規模成長率:タイプ別, 2017 VS 2021 VS 2028
    • DTaP
    • Tdap
    • DTwP
  • 市場:アプリケーション別
    • 世界のDPTワクチン接種の市場規模成長率:アプリケーション別, 2017 VS 2021 VS 2028
    • 12 Months Below
    • 12 Months Above
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界のDPTワクチン接種の販売 推定および予測 2017-2028
  • 世界のDPTワクチン接種の収益 推定および予測 2017-2028
  • 世界のDPTワクチン接種の収益:地域別: 2017 VS 2021 VS 2028
  • 世界のDPTワクチン接種の販売:地域別
    • 世界のDPTワクチン接種の販売:地域別 (2017-2022)
    • 世界の販売 DPTワクチン接種 :地域別 (2023-2028)
  • 世界のDPTワクチン接種の収益:地域別
    • 世界のDPTワクチン接種の収益:地域別 (2017-2022)
    • 世界のDPTワクチン接種の収益:地域別 (2023-2028)
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第3章 競合:メーカー別

  • 世界のDPTワクチン接種の販売:メーカー別
    • 世界のDPTワクチン接種の上位メーカー:販売別 (2017-2022)
    • 世界のDPTワクチン接種の販売市場シェア:メーカー別 (2017-2022)
    • 世界の上位10・上位5メーカー: DPTワクチン接種2021
  • 世界のDPTワクチン接種の収益:メーカー別
    • 世界のDPTワクチン接種の収益:メーカー別 (2017-2022)
    • 世界のDPTワクチン接種の収益市場シェア:メーカー別 (2017-2022)
    • 世界の上位10・上位5企業: DPTワクチン接種の収益 2021
  • 世界のDPTワクチン接種の販売価格:メーカー別 (2017-2022)
  • 競合情勢の分析
    • メーカーの市場集中度 (CR5 and HHI)
    • 世界のDPTワクチン接種の市場シェア:企業タイプ別 (Tier 1, Tier 2, and Tier 3)
    • 世界のDPTワクチン接種のメーカーの地理的分布
  • M&A, 拡張計画

第4章 市場規模:タイプ別

  • 世界のDPTワクチン接種の販売:タイプ別
    • 世界のDPTワクチン接種の販売実績:タイプ別 (2017-2022)
    • 世界のDPTワクチン接種の販売予測:タイプ別 (2023-2028)
    • 世界のDPTワクチン接種の販売市場シェア:タイプ別 (2017-2028)
  • 世界のDPTワクチン接種の収益:タイプ別
    • 世界のDPTワクチン接種の収益実績:タイプ別 (2017-2022)
    • 世界のDPTワクチン接種の収益予測:タイプ別 (2023-2028)
    • 世界のDPTワクチン接種の収益市場シェア:タイプ別 (2017-2028)
  • 世界のDPTワクチン接種の価格:タイプ別
    • 世界のDPTワクチン接種の価格:タイプ別 (2017-2022)
    • 世界のDPTワクチン接種の価格予測:タイプ別 (2023-2028)

第5章 市場規模:アプリケーション別

  • 世界のDPTワクチン接種の販売:アプリケーション別
    • 世界のDPTワクチン接種の販売実績:アプリケーション別 (2017-2022)
    • 世界のDPTワクチン接種の販売予測:アプリケーション別 (2023-2028)
    • 世界のDPTワクチン接種の販売市場シェア:アプリケーション別 (2017-2028)
  • 世界のDPTワクチン接種の収益:アプリケーション別
    • 世界のDPTワクチン接種の収益実績:アプリケーション別 (2017-2022)
    • 世界のDPTワクチン接種の収益予測:アプリケーション別 (2023-2028)
    • 世界のDPTワクチン接種の収益市場シェア:アプリケーション別 (2017-2028)
  • 世界のDPTワクチン接種の価格:アプリケーション別
    • 世界のDPTワクチン接種の価格:アプリケーション別 (2017-2022)
    • 世界のDPTワクチン接種の価格予測:アプリケーション別 (2023-2028)

第6章 北米

  • 北米のDPTワクチン接種 市場規模:タイプ別
    • 北米のDPTワクチン接種の販売:タイプ別 (2017-2028)
    • 北米のDPTワクチン接種の収益:タイプ別 (2017-2028)
  • 北米のDPTワクチン接種 市場規模:アプリケーション別
    • 北米のDPTワクチン接種の販売:アプリケーション別 (2017-2028)
    • 北米のDPTワクチン接種の収益:アプリケーション別 (2017-2028)
  • 北米のDPTワクチン接種 市場規模:国別
    • 北米のDPTワクチン接種の販売:国別 (2017-2028)
    • 北米のDPTワクチン接種の収益:国別 (2017-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州のDPTワクチン接種 市場規模:タイプ別
    • 欧州のDPTワクチン接種の販売:タイプ別 (2017-2028)
    • 欧州のDPTワクチン接種の収益:タイプ別 (2017-2028)
  • 欧州のDPTワクチン接種 市場規模:アプリケーション別
    • 欧州のDPTワクチン接種の販売:アプリケーション別 (2017-2028)
    • 欧州のDPTワクチン接種の収益:アプリケーション別 (2017-2028)
  • 欧州のDPTワクチン接種 市場規模:国別
    • 欧州のDPTワクチン接種の販売:国別 (2017-2028)
    • 欧州のDPTワクチン接種の収益:国別 (2017-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋

  • アジア太平洋のDPTワクチン接種 市場規模:タイプ別
    • アジア太平洋のDPTワクチン接種の販売:タイプ別 (2017-2028)
    • アジア太平洋のDPTワクチン接種の収益:タイプ別 (2017-2028)
  • アジア太平洋のDPTワクチン接種 市場規模:アプリケーション別
    • アジア太平洋のDPTワクチン接種の販売:アプリケーション別 (2017-2028)
    • アジア太平洋のDPTワクチン接種の収益:アプリケーション別 (2017-2028)
  • アジア太平洋のDPTワクチン接種 市場規模:地域別
    • アジア太平洋のDPTワクチン接種の販売:地域別 (2017-2028)
    • アジア太平洋のDPTワクチン接種の収益:地域別 (2017-2028)
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 中国の台湾
    • インドネシア
    • タイ
    • マレーシア

第9章 ラテンアメリカ

  • ラテンアメリカのDPTワクチン接種 市場規模:タイプ別
    • ラテンアメリカのDPTワクチン接種の販売:タイプ別 (2017-2028)
    • ラテンアメリカのDPTワクチン接種の収益:タイプ別 (2017-2028)
  • ラテンアメリカのDPTワクチン接種 市場規模:アプリケーション別
    • ラテンアメリカのDPTワクチン接種の販売:アプリケーション別 (2017-2028)
    • ラテンアメリカのDPTワクチン接種の収益:アプリケーション別 (2017-2028)
  • ラテンアメリカのDPTワクチン接種 市場規模:国別
    • ラテンアメリカのDPTワクチン接種の販売:国別 (2017-2028)
    • ラテンアメリカのDPTワクチン接種の収益:国別 (2017-2028)
    • メキシコ
    • ブラジル
    • アルゼンチン

第10章 中東・アフリカ

  • 中東・アフリカのDPTワクチン接種 市場規模:タイプ別
    • 中東・アフリカのDPTワクチン接種の販売:タイプ別 (2017-2028)
    • 中東・アフリカのDPTワクチン接種の収益:タイプ別 (2017-2028)
  • 中東・アフリカのDPTワクチン接種 市場規模:アプリケーション別
    • 中東・アフリカのDPTワクチン接種の販売:アプリケーション別 (2017-2028)
    • 中東・アフリカのDPTワクチン接種の収益:アプリケーション別 (2017-2028)
  • 中東・アフリカのDPTワクチン接種 市場規模:国別
    • 中東・アフリカのDPTワクチン接種の販売:国別 (2017-2028)
    • 中東・アフリカのDPTワクチン接種の収益:国別 (2017-2028)
    • トルコ
    • サウジアラビア

第11章 企業プロファイル

  • Sanofi Pasteur
  • GSK
  • Mitsubishi Tanabe Pharma
  • KM Biologics
  • Wuhan Institute of Biological Products
  • Walvax Biotechnology
  • Chengdu Institute of Biological Products
  • Minhai Biotechnology

第12章 業界チェーンと販売チャネルの分析

  • DPTワクチン接種 業界チェーン分析
  • DPTワクチン接種 主要原材料分析
    • 主要原材料分析
    • 原材料の主要サプライヤー
  • DPTワクチン接種 生産形態とプロセス
  • DPTワクチン接種 販売およびマーケティング
    • DPTワクチン接種 販売チャネル
    • DPTワクチン接種 卸業者
  • DPTワクチン接種 顧客

第13章 市場の促進要因, 機会, 課題とリスク要因の分析

  • DPTワクチン接種 業界動向
  • DPTワクチン接種 市場の促進要因
  • DPTワクチン接種 市場の課題
  • DPTワクチン接種 市場の抑制要因

第14章 世界のDPTワクチン接種の主な市場調査結果

第15章 付録

図表

List of Tables

  • Table 1. Global DPT Vaccination Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of DTaP
  • Table 3. Major Manufacturers of Tdap
  • Table 4. Major Manufacturers of DTwP
  • Table 5. Global DPT Vaccination Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 6. Global DPT Vaccination Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 7. Global DPT Vaccination Sales by Region (2017-2022) & (Units)
  • Table 8. Global DPT Vaccination Sales Market Share by Region (2017-2022)
  • Table 9. Global DPT Vaccination Sales by Region (2023-2028) & (Units)
  • Table 10. Global DPT Vaccination Sales Market Share by Region (2023-2028)
  • Table 11. Global DPT Vaccination Revenue by Region (2017-2022) & (US$ Million)
  • Table 12. Global DPT Vaccination Revenue Market Share by Region (2017-2022)
  • Table 13. Global DPT Vaccination Revenue by Region (2023-2028) & (US$ Million)
  • Table 14. Global DPT Vaccination Revenue Market Share by Region (2023-2028)
  • Table 15. Global DPT Vaccination Sales by Manufacturers (2017-2022) & (Units)
  • Table 16. Global DPT Vaccination Sales Share by Manufacturers (2017-2022)
  • Table 17. Global DPT Vaccination Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 18. Global DPT Vaccination Revenue Share by Manufacturers (2017-2022)
  • Table 19. DPT Vaccination Price by Manufacturers (2017-2022) &(US$/Unit)
  • Table 20. Global DPT Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 21. Global DPT Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DPT Vaccination as of 2021)
  • Table 22. DPT Vaccination Manufacturing Base Distribution and Headquarters
  • Table 23. Manufacturers DPT Vaccination Product Offered
  • Table 24. Date of Manufacturers Enter into DPT Vaccination Market
  • Table 25. Mergers & Acquisitions, Expansion Plans
  • Table 26. Global DPT Vaccination Sales by Type (2017-2022) & (Units)
  • Table 27. Global DPT Vaccination Sales by Type (2023-2028) & (Units)
  • Table 28. Global DPT Vaccination Sales Share by Type (2017-2022)
  • Table 29. Global DPT Vaccination Sales Share by Type (2023-2028)
  • Table 30. Global DPT Vaccination Revenue by Type (2017-2022) & (US$ Million)
  • Table 31. Global DPT Vaccination Revenue by Type (2023-2028) & (US$ Million)
  • Table 32. Global DPT Vaccination Revenue Share by Type (2017-2022)
  • Table 33. Global DPT Vaccination Revenue Share by Type (2023-2028)
  • Table 34. DPT Vaccination Price by Type (2017-2022) & (US$/Unit)
  • Table 35. Global DPT Vaccination Price Forecast by Type (2023-2028) & (US$/Unit)
  • Table 36. Global DPT Vaccination Sales by Application (2017-2022) & (Units)
  • Table 37. Global DPT Vaccination Sales by Application (2023-2028) & (Units)
  • Table 38. Global DPT Vaccination Sales Share by Application (2017-2022)
  • Table 39. Global DPT Vaccination Sales Share by Application (2023-2028)
  • Table 40. Global DPT Vaccination Revenue by Application (2017-2022) & (US$ Million)
  • Table 41. Global DPT Vaccination Revenue by Application (2023-2028) & (US$ Million)
  • Table 42. Global DPT Vaccination Revenue Share by Application (2017-2022)
  • Table 43. Global DPT Vaccination Revenue Share by Application (2023-2028)
  • Table 44. DPT Vaccination Price by Application (2017-2022) & (US$/Unit)
  • Table 45. Global DPT Vaccination Price Forecast by Application (2023-2028) & (US$/Unit)
  • Table 46. North America DPT Vaccination Sales by Type (2017-2022) & (Units)
  • Table 47. North America DPT Vaccination Sales by Type (2023-2028) & (Units)
  • Table 48. North America DPT Vaccination Revenue by Type (2017-2022) & (US$ Million)
  • Table 49. North America DPT Vaccination Revenue by Type (2023-2028) & (US$ Million)
  • Table 50. North America DPT Vaccination Sales by Application (2017-2022) & (Units)
  • Table 51. North America DPT Vaccination Sales by Application (2023-2028) & (Units)
  • Table 52. North America DPT Vaccination Revenue by Application (2017-2022) & (US$ Million)
  • Table 53. North America DPT Vaccination Revenue by Application (2023-2028) & (US$ Million)
  • Table 54. North America DPT Vaccination Sales by Country (2017-2022) & (Units)
  • Table 55. North America DPT Vaccination Sales by Country (2023-2028) & (Units)
  • Table 56. North America DPT Vaccination Revenue by Country (2017-2022) & (US$ Million)
  • Table 57. North America DPT Vaccination Revenue by Country (2023-2028) & (US$ Million)
  • Table 58. Europe DPT Vaccination Sales by Type (2017-2022) & (Units)
  • Table 59. Europe DPT Vaccination Sales by Type (2023-2028) & (Units)
  • Table 60. Europe DPT Vaccination Revenue by Type (2017-2022) & (US$ Million)
  • Table 61. Europe DPT Vaccination Revenue by Type (2023-2028) & (US$ Million)
  • Table 62. Europe DPT Vaccination Sales by Application (2017-2022) & (Units)
  • Table 63. Europe DPT Vaccination Sales by Application (2023-2028) & (Units)
  • Table 64. Europe DPT Vaccination Revenue by Application (2017-2022) & (US$ Million)
  • Table 65. Europe DPT Vaccination Revenue by Application (2023-2028) & (US$ Million)
  • Table 66. Europe DPT Vaccination Sales by Country (2017-2022) & (Units)
  • Table 67. Europe DPT Vaccination Sales by Country (2023-2028) & (Units)
  • Table 68. Europe DPT Vaccination Revenue by Country (2017-2022) & (US$ Million)
  • Table 69. Europe DPT Vaccination Revenue by Country (2023-2028) & (US$ Million)
  • Table 70. Asia Pacific DPT Vaccination Sales by Type (2017-2022) & (Units)
  • Table 71. Asia Pacific DPT Vaccination Sales by Type (2023-2028) & (Units)
  • Table 72. Asia Pacific DPT Vaccination Revenue by Type (2017-2022) & (US$ Million)
  • Table 73. Asia Pacific DPT Vaccination Revenue by Type (2023-2028) & (US$ Million)
  • Table 74. Asia Pacific DPT Vaccination Sales by Application (2017-2022) & (Units)
  • Table 75. Asia Pacific DPT Vaccination Sales by Application (2023-2028) & (Units)
  • Table 76. Asia Pacific DPT Vaccination Revenue by Application (2017-2022) & (US$ Million)
  • Table 77. Asia Pacific DPT Vaccination Revenue by Application (2023-2028) & (US$ Million)
  • Table 78. Asia Pacific DPT Vaccination Sales by Region (2017-2022) & (Units)
  • Table 79. Asia Pacific DPT Vaccination Sales by Region (2023-2028) & (Units)
  • Table 80. Asia Pacific DPT Vaccination Revenue by Region (2017-2022) & (US$ Million)
  • Table 81. Asia Pacific DPT Vaccination Revenue by Region (2023-2028) & (US$ Million)
  • Table 82. Latin America DPT Vaccination Sales by Type (2017-2022) & (Units)
  • Table 83. Latin America DPT Vaccination Sales by Type (2023-2028) & (Units)
  • Table 84. Latin America DPT Vaccination Revenue by Type (2017-2022) & (US$ Million)
  • Table 85. Latin America DPT Vaccination Revenue by Type (2023-2028) & (US$ Million)
  • Table 86. Latin America DPT Vaccination Sales by Application (2017-2022) & (Units)
  • Table 87. Latin America DPT Vaccination Sales by Application (2023-2028) & (Units)
  • Table 88. Latin America DPT Vaccination Revenue by Application (2017-2022) & (US$ Million)
  • Table 89. Latin America DPT Vaccination Revenue by Application (2023-2028) & (US$ Million)
  • Table 90. Latin America DPT Vaccination Sales by Country (2017-2022) & (Units)
  • Table 91. Latin America DPT Vaccination Sales by Country (2023-2028) & (Units)
  • Table 92. Latin America DPT Vaccination Revenue by Country (2017-2022) & (US$ Million)
  • Table 93. Latin America DPT Vaccination Revenue by Country (2023-2028) & (US$ Million)
  • Table 94. Middle East and Africa DPT Vaccination Sales by Type (2017-2022) & (Units)
  • Table 95. Middle East and Africa DPT Vaccination Sales by Type (2023-2028) & (Units)
  • Table 96. Middle East and Africa DPT Vaccination Revenue by Type (2017-2022) & (US$ Million)
  • Table 97. Middle East and Africa DPT Vaccination Revenue by Type (2023-2028) & (US$ Million)
  • Table 98. Middle East and Africa DPT Vaccination Sales by Application (2017-2022) & (Units)
  • Table 99. Middle East and Africa DPT Vaccination Sales by Application (2023-2028) & (Units)
  • Table 100. Middle East and Africa DPT Vaccination Revenue by Application (2017-2022) & (US$ Million)
  • Table 101. Middle East and Africa DPT Vaccination Revenue by Application (2023-2028) & (US$ Million)
  • Table 102. Middle East and Africa DPT Vaccination Sales by Country (2017-2022) & (Units)
  • Table 103. Middle East and Africa DPT Vaccination Sales by Country (2023-2028) & (Units)
  • Table 104. Middle East and Africa DPT Vaccination Revenue by Country (2017-2022) & (US$ Million)
  • Table 105. Middle East and Africa DPT Vaccination Revenue by Country (2023-2028) & (US$ Million)
  • Table 106. Sanofi Pasteur Corporation Information
  • Table 107. Sanofi Pasteur Description and Major Businesses
  • Table 108. Sanofi Pasteur DPT Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 109. Sanofi Pasteur DPT Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 110. Sanofi Pasteur Recent Developments
  • Table 111. GSK Corporation Information
  • Table 112. GSK Description and Major Businesses
  • Table 113. GSK DPT Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 114. GSK DPT Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 115. GSK Recent Developments
  • Table 116. Mitsubishi Tanabe Pharma Corporation Information
  • Table 117. Mitsubishi Tanabe Pharma Description and Major Businesses
  • Table 118. Mitsubishi Tanabe Pharma DPT Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 119. Mitsubishi Tanabe Pharma DPT Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 120. Mitsubishi Tanabe Pharma Recent Developments
  • Table 121. KM Biologics Corporation Information
  • Table 122. KM Biologics Description and Major Businesses
  • Table 123. KM Biologics DPT Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 124. KM Biologics DPT Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 125. KM Biologics Recent Developments
  • Table 126. Wuhan Institute of Biological Products Corporation Information
  • Table 127. Wuhan Institute of Biological Products Description and Major Businesses
  • Table 128. Wuhan Institute of Biological Products DPT Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 129. Wuhan Institute of Biological Products DPT Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 130. Wuhan Institute of Biological Products Recent Developments
  • Table 131. Walvax Biotechnology Corporation Information
  • Table 132. Walvax Biotechnology Description and Major Businesses
  • Table 133. Walvax Biotechnology DPT Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 134. Walvax Biotechnology DPT Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 135. Walvax Biotechnology Recent Developments
  • Table 136. Chengdu Institute of Biological Products Corporation Information
  • Table 137. Chengdu Institute of Biological Products Description and Major Businesses
  • Table 138. Chengdu Institute of Biological Products DPT Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 139. Chengdu Institute of Biological Products DPT Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 140. Chengdu Institute of Biological Products Recent Developments
  • Table 141. Minhai Biotechnology Corporation Information
  • Table 142. Minhai Biotechnology Description and Major Businesses
  • Table 143. Minhai Biotechnology DPT Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 144. Minhai Biotechnology DPT Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 145. Minhai Biotechnology Recent Developments
  • Table 146. Key Raw Materials Lists
  • Table 147. Raw Materials Key Suppliers Lists
  • Table 148. DPT Vaccination Distributors List
  • Table 149. DPT Vaccination Customers List
  • Table 150. DPT Vaccination Market Trends
  • Table 151. DPT Vaccination Market Drivers
  • Table 152. DPT Vaccination Market Challenges
  • Table 153. DPT Vaccination Market Restraints
  • Table 154. Research Programs/Design for This Report
  • Table 155. Key Data Information from Secondary Sources
  • Table 156. Key Data Information from Primary Sources

List of Figures

  • Figure 1. DPT Vaccination Product Picture
  • Figure 3. Global DPT Vaccination Market Share by Type in 2021 & 2028
  • Figure 3. DTaP Product Picture
  • Figure 4. Tdap Product Picture
  • Figure 5. DTwP Product Picture
  • Figure 6. Global DPT Vaccination Market Share by Application in 2021 & 2028
  • Figure 7. 12 Months Below
  • Figure 8. 12 Months Above
  • Figure 9. DPT Vaccination Report Years Considered
  • Figure 10. Global DPT Vaccination Sales 2017-2028 (Units)
  • Figure 11. Global DPT Vaccination Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 12. Global DPT Vaccination Revenue 2017-2028 (US$ Million)
  • Figure 13. Global DPT Vaccination Revenue Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 14. Global DPT Vaccination Sales Market Share by Region (2017-2022)
  • Figure 15. Global DPT Vaccination Sales Market Share by Region (2023-2028)
  • Figure 16. North America DPT Vaccination Sales YoY (2017-2028) & (Units)
  • Figure 17. North America DPT Vaccination Revenue YoY (2017-2028) & (US$ Million)
  • Figure 18. Europe DPT Vaccination Sales YoY (2017-2028) & (Units)
  • Figure 19. Europe DPT Vaccination Revenue YoY (2017-2028) & (US$ Million)
  • Figure 20. Asia-Pacific DPT Vaccination Sales YoY (2017-2028) & (Units)
  • Figure 21. Asia-Pacific DPT Vaccination Revenue YoY (2017-2028) & (US$ Million)
  • Figure 22. Latin America DPT Vaccination Sales YoY (2017-2028) & (Units)
  • Figure 23. Latin America DPT Vaccination Revenue YoY (2017-2028) & (US$ Million)
  • Figure 24. Middle East & Africa DPT Vaccination Sales YoY (2017-2028) & (Units)
  • Figure 25. Middle East & Africa DPT Vaccination Revenue YoY (2017-2028) & (US$ Million)
  • Figure 26. The DPT Vaccination Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
  • Figure 27. The Top 5 and 10 Largest Manufacturers of DPT Vaccination in the World: Market Share by DPT Vaccination Revenue in 2021
  • Figure 28. Global DPT Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 29. Global DPT Vaccination Sales Market Share by Type (2017-2028)
  • Figure 30. Global DPT Vaccination Revenue Market Share by Type (2017-2028)
  • Figure 31. Global DPT Vaccination Sales Market Share by Application (2017-2028)
  • Figure 32. Global DPT Vaccination Revenue Market Share by Application (2017-2028)
  • Figure 33. North America DPT Vaccination Sales Market Share by Type (2017-2028)
  • Figure 34. North America DPT Vaccination Revenue Market Share by Type (2017-2028)
  • Figure 35. North America DPT Vaccination Sales Market Share by Application (2017-2028)
  • Figure 36. North America DPT Vaccination Revenue Market Share by Application (2017-2028)
  • Figure 37. North America DPT Vaccination Sales Share by Country (2017-2028)
  • Figure 38. North America DPT Vaccination Revenue Share by Country (2017-2028)
  • Figure 39. United States DPT Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 40. Canada DPT Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 41. Europe DPT Vaccination Sales Market Share by Type (2017-2028)
  • Figure 42. Europe DPT Vaccination Revenue Market Share by Type (2017-2028)
  • Figure 43. Europe DPT Vaccination Sales Market Share by Application (2017-2028)
  • Figure 44. Europe DPT Vaccination Revenue Market Share by Application (2017-2028)
  • Figure 45. Europe DPT Vaccination Sales Share by Country (2017-2028)
  • Figure 46. Europe DPT Vaccination Revenue Share by Country (2017-2028)
  • Figure 47. Germany DPT Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 48. France DPT Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 49. U.K. DPT Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 50. Italy DPT Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 51. Russia DPT Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 52. Asia Pacific DPT Vaccination Sales Market Share by Type (2017-2028)
  • Figure 53. Asia Pacific DPT Vaccination Revenue Market Share by Type (2017-2028)
  • Figure 54. Asia Pacific DPT Vaccination Sales Market Share by Application (2017-2028)
  • Figure 55. Asia Pacific DPT Vaccination Revenue Market Share by Application (2017-2028)
  • Figure 56. Asia Pacific DPT Vaccination Sales Share by Region (2017-2028)
  • Figure 57. Asia Pacific DPT Vaccination Revenue Share by Region (2017-2028)
  • Figure 58. China DPT Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 59. Japan DPT Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 60. South Korea DPT Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 61. India DPT Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 62. Australia DPT Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 63. China Taiwan DPT Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 64. Indonesia DPT Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 65. Thailand DPT Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 66. Malaysia DPT Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 67. Latin America DPT Vaccination Sales Market Share by Type (2017-2028)
  • Figure 68. Latin America DPT Vaccination Revenue Market Share by Type (2017-2028)
  • Figure 69. Latin America DPT Vaccination Sales Market Share by Application (2017-2028)
  • Figure 70. Latin America DPT Vaccination Revenue Market Share by Application (2017-2028)
  • Figure 71. Latin America DPT Vaccination Sales Share by Country (2017-2028)
  • Figure 72. Latin America DPT Vaccination Revenue Share by Country (2017-2028)
  • Figure 73. Mexico DPT Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 74. Brazil DPT Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 75. Argentina DPT Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 76. Middle East and Africa DPT Vaccination Sales Market Share by Type (2017-2028)
  • Figure 77. Middle East and Africa DPT Vaccination Revenue Market Share by Type (2017-2028)
  • Figure 78. Middle East and Africa DPT Vaccination Sales Market Share by Application (2017-2028)
  • Figure 79. Middle East and Africa DPT Vaccination Revenue Market Share by Application (2017-2028)
  • Figure 80. Middle East and Africa DPT Vaccination Sales Share by Country (2017-2028)
  • Figure 81. Middle East and Africa DPT Vaccination Revenue Share by Country (2017-2028)
  • Figure 82. Turkey DPT Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 83. Saudi Arabia DPT Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 84. UAE DPT Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 85. DPT Vaccination Value Chain
  • Figure 86. DPT Vaccination Production Process
  • Figure 87. Channels of Distribution
  • Figure 88. Distributors Profiles
  • Figure 89. Bottom-up and Top-down Approaches for This Report
  • Figure 90. Data Triangulation
  • Figure 91. Key Executives Interviewed
目次

This research report focuses on the DPT Vaccination Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 DPT Vaccination Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global DPT Vaccination Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 DTaP
    • 1.2.3 Tdap
    • 1.2.4 DTwP
  • 1.3 Market by Application
    • 1.3.1 Global DPT Vaccination Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 12 Months Below
    • 1.3.3 12 Months Above
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global DPT Vaccination Sales Estimates and Forecasts 2017-2028
  • 2.2 Global DPT Vaccination Revenue Estimates and Forecasts 2017-2028
  • 2.3 Global DPT Vaccination Revenue by Region: 2017 VS 2021 VS 2028
  • 2.4 Global DPT Vaccination Sales by Region
    • 2.4.1 Global DPT Vaccination Sales by Region (2017-2022)
    • 2.4.2 Global Sales DPT Vaccination by Region (2023-2028)
  • 2.5 Global DPT Vaccination Revenue by Region
    • 2.5.1 Global DPT Vaccination Revenue by Region (2017-2022)
    • 2.5.2 Global DPT Vaccination Revenue by Region (2023-2028)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global DPT Vaccination Sales by Manufacturers
    • 3.1.1 Global Top DPT Vaccination Manufacturers by Sales (2017-2022)
    • 3.1.2 Global DPT Vaccination Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of DPT Vaccination in 2021
  • 3.2 Global DPT Vaccination Revenue by Manufacturers
    • 3.2.1 Global DPT Vaccination Revenue by Manufacturers (2017-2022)
    • 3.2.2 Global DPT Vaccination Revenue Market Share by Manufacturers (2017-2022)
    • 3.2.3 Global Top 10 and Top 5 Companies by DPT Vaccination Revenue in 2021
  • 3.3 Global DPT Vaccination Sales Price by Manufacturers (2017-2022)
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global DPT Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global DPT Vaccination Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global DPT Vaccination Sales by Type
    • 4.1.1 Global DPT Vaccination Historical Sales by Type (2017-2022)
    • 4.1.2 Global DPT Vaccination Forecasted Sales by Type (2023-2028)
    • 4.1.3 Global DPT Vaccination Sales Market Share by Type (2017-2028)
  • 4.2 Global DPT Vaccination Revenue by Type
    • 4.2.1 Global DPT Vaccination Historical Revenue by Type (2017-2022)
    • 4.2.2 Global DPT Vaccination Forecasted Revenue by Type (2023-2028)
    • 4.2.3 Global DPT Vaccination Revenue Market Share by Type (2017-2028)
  • 4.3 Global DPT Vaccination Price by Type
    • 4.3.1 Global DPT Vaccination Price by Type (2017-2022)
    • 4.3.2 Global DPT Vaccination Price Forecast by Type (2023-2028)

5 Market Size by Application

  • 5.1 Global DPT Vaccination Sales by Application
    • 5.1.1 Global DPT Vaccination Historical Sales by Application (2017-2022)
    • 5.1.2 Global DPT Vaccination Forecasted Sales by Application (2023-2028)
    • 5.1.3 Global DPT Vaccination Sales Market Share by Application (2017-2028)
  • 5.2 Global DPT Vaccination Revenue by Application
    • 5.2.1 Global DPT Vaccination Historical Revenue by Application (2017-2022)
    • 5.2.2 Global DPT Vaccination Forecasted Revenue by Application (2023-2028)
    • 5.2.3 Global DPT Vaccination Revenue Market Share by Application (2017-2028)
  • 5.3 Global DPT Vaccination Price by Application
    • 5.3.1 Global DPT Vaccination Price by Application (2017-2022)
    • 5.3.2 Global DPT Vaccination Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America DPT Vaccination Market Size by Type
    • 6.1.1 North America DPT Vaccination Sales by Type (2017-2028)
    • 6.1.2 North America DPT Vaccination Revenue by Type (2017-2028)
  • 6.2 North America DPT Vaccination Market Size by Application
    • 6.2.1 North America DPT Vaccination Sales by Application (2017-2028)
    • 6.2.2 North America DPT Vaccination Revenue by Application (2017-2028)
  • 6.3 North America DPT Vaccination Market Size by Country
    • 6.3.1 North America DPT Vaccination Sales by Country (2017-2028)
    • 6.3.2 North America DPT Vaccination Revenue by Country (2017-2028)
    • 6.3.3 United States
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe DPT Vaccination Market Size by Type
    • 7.1.1 Europe DPT Vaccination Sales by Type (2017-2028)
    • 7.1.2 Europe DPT Vaccination Revenue by Type (2017-2028)
  • 7.2 Europe DPT Vaccination Market Size by Application
    • 7.2.1 Europe DPT Vaccination Sales by Application (2017-2028)
    • 7.2.2 Europe DPT Vaccination Revenue by Application (2017-2028)
  • 7.3 Europe DPT Vaccination Market Size by Country
    • 7.3.1 Europe DPT Vaccination Sales by Country (2017-2028)
    • 7.3.2 Europe DPT Vaccination Revenue by Country (2017-2028)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific DPT Vaccination Market Size by Type
    • 8.1.1 Asia Pacific DPT Vaccination Sales by Type (2017-2028)
    • 8.1.2 Asia Pacific DPT Vaccination Revenue by Type (2017-2028)
  • 8.2 Asia Pacific DPT Vaccination Market Size by Application
    • 8.2.1 Asia Pacific DPT Vaccination Sales by Application (2017-2028)
    • 8.2.2 Asia Pacific DPT Vaccination Revenue by Application (2017-2028)
  • 8.3 Asia Pacific DPT Vaccination Market Size by Region
    • 8.3.1 Asia Pacific DPT Vaccination Sales by Region (2017-2028)
    • 8.3.2 Asia Pacific DPT Vaccination Revenue by Region (2017-2028)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 China Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia

9 Latin America

  • 9.1 Latin America DPT Vaccination Market Size by Type
    • 9.1.1 Latin America DPT Vaccination Sales by Type (2017-2028)
    • 9.1.2 Latin America DPT Vaccination Revenue by Type (2017-2028)
  • 9.2 Latin America DPT Vaccination Market Size by Application
    • 9.2.1 Latin America DPT Vaccination Sales by Application (2017-2028)
    • 9.2.2 Latin America DPT Vaccination Revenue by Application (2017-2028)
  • 9.3 Latin America DPT Vaccination Market Size by Country
    • 9.3.1 Latin America DPT Vaccination Sales by Country (2017-2028)
    • 9.3.2 Latin America DPT Vaccination Revenue by Country (2017-2028)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa DPT Vaccination Market Size by Type
    • 10.1.1 Middle East and Africa DPT Vaccination Sales by Type (2017-2028)
    • 10.1.2 Middle East and Africa DPT Vaccination Revenue by Type (2017-2028)
  • 10.2 Middle East and Africa DPT Vaccination Market Size by Application
    • 10.2.1 Middle East and Africa DPT Vaccination Sales by Application (2017-2028)
    • 10.2.2 Middle East and Africa DPT Vaccination Revenue by Application (2017-2028)
  • 10.3 Middle East and Africa DPT Vaccination Market Size by Country
    • 10.3.1 Middle East and Africa DPT Vaccination Sales by Country (2017-2028)
    • 10.3.2 Middle East and Africa DPT Vaccination Revenue by Country (2017-2028)
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia

11 Company Profiles

  • 11.1 Sanofi Pasteur
    • 11.1.1 Sanofi Pasteur Corporation Information
    • 11.1.2 Sanofi Pasteur Overview
    • 11.1.3 Sanofi Pasteur DPT Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.1.4 Sanofi Pasteur DPT Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Sanofi Pasteur Recent Developments
  • 11.2 GSK
    • 11.2.1 GSK Corporation Information
    • 11.2.2 GSK Overview
    • 11.2.3 GSK DPT Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.2.4 GSK DPT Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 GSK Recent Developments
  • 11.3 Mitsubishi Tanabe Pharma
    • 11.3.1 Mitsubishi Tanabe Pharma Corporation Information
    • 11.3.2 Mitsubishi Tanabe Pharma Overview
    • 11.3.3 Mitsubishi Tanabe Pharma DPT Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.3.4 Mitsubishi Tanabe Pharma DPT Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Mitsubishi Tanabe Pharma Recent Developments
  • 11.4 KM Biologics
    • 11.4.1 KM Biologics Corporation Information
    • 11.4.2 KM Biologics Overview
    • 11.4.3 KM Biologics DPT Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.4.4 KM Biologics DPT Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 KM Biologics Recent Developments
  • 11.5 Wuhan Institute of Biological Products
    • 11.5.1 Wuhan Institute of Biological Products Corporation Information
    • 11.5.2 Wuhan Institute of Biological Products Overview
    • 11.5.3 Wuhan Institute of Biological Products DPT Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.5.4 Wuhan Institute of Biological Products DPT Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Wuhan Institute of Biological Products Recent Developments
  • 11.6 Walvax Biotechnology
    • 11.6.1 Walvax Biotechnology Corporation Information
    • 11.6.2 Walvax Biotechnology Overview
    • 11.6.3 Walvax Biotechnology DPT Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.6.4 Walvax Biotechnology DPT Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Walvax Biotechnology Recent Developments
  • 11.7 Chengdu Institute of Biological Products
    • 11.7.1 Chengdu Institute of Biological Products Corporation Information
    • 11.7.2 Chengdu Institute of Biological Products Overview
    • 11.7.3 Chengdu Institute of Biological Products DPT Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.7.4 Chengdu Institute of Biological Products DPT Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Chengdu Institute of Biological Products Recent Developments
  • 11.8 Minhai Biotechnology
    • 11.8.1 Minhai Biotechnology Corporation Information
    • 11.8.2 Minhai Biotechnology Overview
    • 11.8.3 Minhai Biotechnology DPT Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.8.4 Minhai Biotechnology DPT Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Minhai Biotechnology Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 DPT Vaccination Industry Chain Analysis
  • 12.2 DPT Vaccination Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 DPT Vaccination Production Mode & Process
  • 12.4 DPT Vaccination Sales and Marketing
    • 12.4.1 DPT Vaccination Sales Channels
    • 12.4.2 DPT Vaccination Distributors
  • 12.5 DPT Vaccination Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 DPT Vaccination Industry Trends
  • 13.2 DPT Vaccination Market Drivers
  • 13.3 DPT Vaccination Market Challenges
  • 13.4 DPT Vaccination Market Restraints

14 Key Findings in The Global DPT Vaccination Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer